Investment
Features
FeesSafety
Academy
More
Pluang+

Compare NEOS S&P 500 High Income ETF (SPYI) vs Tenet Healthcare Corporation (THC) Price & Performance

NEOS S&P 500 High Income ETFTrade
Tenet Healthcare CorporationTrade

Price performance (Past 24H)

Key statistics

NEOS S&P 500 High Income ETF vs Tenet Healthcare Corporation — how do they compare? NEOS S&P 500 High Income ETF trades at $53.42, while Tenet Healthcare Corporation trades at $196.03 (market cap $16.74B). The key difference: NEOS S&P 500 High Income ETF is trading nearer its 52-week high, Tenet Healthcare Corporation nearer its low. Which is the better fit depends on your goals.

SPYITHC
Sector
Income / Options OverlayHealth
52-Week High
$54.07$244.80
52-Week Low
$47.98$148.38
Market Cap
$16.74B
Enterprise Value
$26.99B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About NEOS S&P 500 High Income ETF

SPYI is an actively managed ETF designed to generate high monthly income through a data-driven call option strategy on the S&P 500 Index. Unlike traditional covered call funds that often forfeit significant upside, SPYI utilizes a 'call spread' approach—selling near-the-money calls while buying out-of-the-money calls—to capture a portion of equity appreciation in rising markets. It prioritizes tax efficiency by utilizing Section 1256 contracts and tax-loss harvesting to provide investors with high-yield monthly distributions.

Read more on SPYI

About Tenet Healthcare Corporation

Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.

Read more on THC